Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.38
-0.10 (-1.54%)
At close: May 30, 2025, 4:00 PM
6.64
+0.26 (4.08%)
After-hours: May 30, 2025, 4:23 PM EDT
DAWN Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for DAWN stock ranges from a low of $25 to a high of $40. The average analyst price target of $31.57 forecasts a 394.83% increase in the stock price over the next year.
Price Target: $31.57 (+394.83%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DAWN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $30 → $27 | Strong Buy | Maintains | $30 → $27 | +323.20% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +464.26% | Apr 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $39 → $27 | Strong Buy | Maintains | $39 → $27 | +323.20% | Mar 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $34 | Buy | Maintains | $39 → $34 | +432.92% | Mar 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $32 | Buy | Reiterates | $32 | +401.57% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
154.74M
from 131.16M
Increased by 17.98%
Revenue Next Year
231.34M
from 154.74M
Increased by 49.50%
EPS This Year
-1.41
from -1.02
EPS Next Year
-0.82
from -1.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 169.1M | 309.3M | 477.8M | ||
| Avg | 154.7M | 231.3M | 382.7M | ||
| Low | 136.2M | 167.7M | 255.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.9% | 99.9% | 106.5% | ||
| Avg | 18.0% | 49.5% | 65.4% | ||
| Low | 3.9% | 8.4% | 10.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.22 | -0.16 | 1.27 | ||
| Avg | -1.41 | -0.82 | 0.53 | ||
| Low | -1.51 | -1.62 | -0.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.